BullFrog AI's bfLEAP platform identifies 3x increase in overall survivability in pancreatic cancer patient subgroups through key biomarkers.

BullFrog AI's bfLEAP platform identified a 3x increase in overall survivability in patient subgroups with pancreatic cancer through key biomarkers. The study used data from a clinical trial to discover key biomarkers that influenced an almost threefold increase in mean survival from the control to treatment arms. The findings highlight the effectiveness of data-driven clustering approaches to refine patient stratification and guide personalized treatment strategies.